Resultados de procura - Carl Christoph Schimanski

  • Mostrando 1 - 5 Resultados de 5
Limitar resultados
  1. 1
    Autocrine CSF-1 and CSF-1 Receptor Coexpression Promotes Renal Cell Carcinoma Growth

    Autocrine CSF-1 and CSF-1 Receptor Coexpression Promotes Renal Cell Carcinoma Growth por Julia Menke, Jörg Kriegsmann, Carl Christoph Schimanski, Melvin M. Schwartz, Andreas Schwarting, Vicki Rubin Kelley

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells

    High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells por Carl Christoph Schimanski, Kirsten Frerichs, Fareed Rahman, Martin D. Berger, Hauke Lang, Peter R. Galle, Markus Moehler, Ines Gockel

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program

    Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO... por Markus Moehler, Irina Gepfner‐Tuma, Annett Maderer, Peter Thuss‐Patience, Joern Ruessel, Susanna Hegewisch‐Becker, H. Wilke, Salah‐Eddin Al‐Batran, Mohammad‐Reza Rafiyan, Florian Weißinger, Hans‐Joachim Schmoll, Frank Kullmann, Ludwig Fischer von Weikersthal, Jens T. Siveke, Jens Weusmann, Stephan Kanzler, Carl Christoph Schimanski, Melanie Otte, Lukas Schollenberger, Jochem Koenig, Peter R. Galle

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

    Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group por Thomas Seufferlein, Waldemar Uhl, Marko Kornmann, Hana Algül, Helmut Friess, Alexander König, Michael Ghadimi, Eike Gallmeier, Detlef K. Bartsch, Manfred P. Lutz, Ralf Metzger, Kai Wille, B. Gerdes, Carl Christoph Schimanski, F Graupe, Volker Kunzmann, Ingo Klein, Michael Geißler, Ludger Staib, D. Waldschmidt, Christiane J. Bruns, Uwe A. Wittel, Stefan Fichtner‐Feigl, S Daum, Axel Hinke, L. Blomé, Andrea Tannapfel, Alexander Kleger, Adam Berger, Angelika Kestler, J.S. Schuhbaur, Lukas Perkhofer, Margaret A. Tempero, Anke Reinacher‐Schick, Thomas Jens Ettrich

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial por Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus A. Weigand, Christian Nußhag, Lars Bullinger, Jens Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria J. G. T. Vehreschild, Stefan Schmiedel, Marylyn M. Addo, Felix J.F. Herth, Michael Kreuter, Phil‐Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl Christoph Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried V. Kern, Anita Schmitt, Hanns‐Martin Lorenz, Margarida Souto‐Carneiro, Mary Gaeddert, Niels Halama, Stefan Meuer, Hans‐Georg Kräusslich, Bárbara Müller, Paul Schnitzler, Sylvia Parthé, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Michael Schmitt, Peter Dreger, Katharina Kriegsmann, Richard F. Schlenk, Carsten Müller‐Tidow

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: